Using Comparative Effectiveness Research to Inform Policymaking – Commonwealth Fund – 4 April 2012

Posted on April 24, 2012. Filed under: Evidence Based Practice | Tags: , |

Using Comparative Effectiveness Research to Inform Policymaking – Commonwealth Fund – 4 April 2012

by David Squires

“Comparative effectiveness research (CER) assesses alternative treatments or diagnostic options for the same condition. Such research can prove useful for clinicians and patients as a tool to inform decisions about treatment and care. It also has potential to inform policymaking, such as decisions over which treatments to cover and at what price. In the United States, the 2009 Recovery Act for the first time provided significant funding for CER, and the 2010 Affordable Care Act went further, establishing an independent institute to commission such research—the Patient-Centered Outcomes Research Institute—with dedicated long-term funding.

Several industrialized countries have operated organizations conducting and commissioning CER for many years. In some countries these bodies are government agencies, while in others they are freestanding organizations with more independence. Policymakers often use the research these organizations generate to determine the content of publicly provided health benefits—for example, to decide whether a new drug should be covered under regional or national formularies. Other uses include negotiating pricing arrangements with drug companies or designing “value-based” cost-sharing arrangements, wherein patients pay more out-of-pocket for drugs deemed less effective than their alternative. As the Patient-Centered Outcomes Research Institute develops and CER becomes more widely available, U.S. decision-makers can learn from international experiences using CER to drive health care toward improved quality and value.”

… continues on the site

Looks at:
England’s National Institute for Health and Clinical Excellence
France’s National Authority for Health (HAS)
Germany’s Institute for Quality and Efficiency in Health Care
Australia’s Pharmaceutical Benefits Advisory Committee


Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: